05:51 PM EDT, 09/09/2024 (MT Newswires) -- Heinrich Dreismann, Director, on September 09, 2024, sold 10,000 shares in Myriad Genetics ( MYGN ) for $270,520. Following the Form 4 filing with the SEC, Dreismann has control over a total of 121,648 shares of the company, with 121,648 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/899923/000137937224000002/xslF345X05/wk-form4_1725918488.xml